Gene therapy represents one of the most rapidly expanding areas of molecular medicine, holding enormous potential to enhance human health. The recent breakthrough has deepened its clinical application, thereby challenging conventional treatment paradigms and enabling gene-based interventions to be tested in a variety of diseases. Improvements in recombinant DNA technology have been a significant factor in this transition, allowing the early detection of genetic diseases, prenatal genetic screening, and informed genetic counseling. Gene therapy modalities are attractive to clinicians and researchers as a potential cure for the treatment of inherited disorders like hemophilia, cystic fibrosis, and familial hypercholesterolemia, as well as for the development of such conditions as cancer, neurodegenerative diseases, and chronic viral infections like HIV. These changes have ushered in a new era of therapeutic possibilities for patients, including those born with congenital diseases. The successful clinical translation, however, hinges on the safety, efficacy, and risk-benefit ratio being thoroughly and rigorously evaluated, especially in terms of achieving stable, long-term gene expression and minimizing side effects.